Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04410510` - P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19	Phase 2/Phase 3
Withdrawn	`NCT04456426` - Characteristics of Patients With COVID-19 in Meta State, Colombia
Withdrawn	`NCT04386447` - Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19	Phase 2
Suspended	`NCT04385771` - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	N/A
Terminated	`NCT04435457` - Cardiovascular Implications of COVID-19
Completed	`NCT04357834` - WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories
Completed	`NCT04405934` - COG-UK Project Hospital-Onset COVID-19 Infections Study	N/A
Completed	`NCT04615936` - Nasal Photodisinfection COVID-19 Proof of Concept Study	N/A
Completed	`NCT04369794` - COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement	Phase 4
Terminated	`NCT04401410` - Anti-SARS Cov-2 T Cell Infusions for COVID 19	Phase 1
Completed	`NCT04542850` - Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19	N/A
Completed	`NCT04382040` - A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19	Phase 2
Completed	`NCT04378582` - Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
Completed	`NCT04366908` - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome	Phase 2
Completed	`NCT04383587` - Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers	N/A
Recruiting	`NCT04402814` - IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
Completed	`NCT04425889` - COVID-19 Antibodies Among Healthcare Workers
Completed	`NCT04395924` - Maternal-foetal Transmission of SARS-Cov-2
Completed	`NCT04374565` - Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia	Phase 2
Not yet recruiting	`NCT04405492` - Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19	N/A

NCT number	NCT04366245
Study type	Interventional
Source	Andalusian Network for Design and Translation of Advanced Therapies
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	April 23, 2020
Completion date	December 30, 2020

Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms